Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 6/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.66 |
| ▸ | HPGD | P15428 | 3/20 | 0.66 |
| ▸ | HTR2C | P28335 | 3/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.66 |
| ▸ | HTR1A | P08908 | 2/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.66 |
| ▸ | DRD2 | P14416 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | HTR7 | P34969 | 2/20 | 0.66 |
| ▸ | HTR6 | P50406 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.66 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.66 |
| ▸ | DRD1 | P21728 | 1/20 | 0.66 |
| ▸ | DRD4 | P21917 | 1/20 | 0.66 |
| ▸ | HTR1D | P28221 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3890962 | 1.00 | HTR2A (0.66) | HTR2ACYP3A4HPGDHTR2CCYP1A2 | |
| SCHEMBL11014375 | 0.87 | HTR2A (0.63) | HTR2ACYP3A4HPGDHTR2CCYP1A2 | |
| Hydrochloric Acid SCHEMBL6402659 | 0.87 | HTR2A (0.58) | HTR2ACYP3A4HPGDHTR2CCYP1A2 | |
| SCHEMBL11495934 | 0.86 | HTR2A (0.62) | HTR2ACYP3A4HPGDHTR2CCYP1A2 | |
| SCHEMBL2946959 | 0.83 | CYP2D6 (0.59) | HTR2ACYP3A4HPGDHTR2CCYP1A2 | |
| Hydrochloric Acid SCHEMBL8025211 | 0.82 | HTR2A (0.60) | HTR2ACYP3A4HPGDHTR2CCYP1A2 | |
| Hydrochloric Acid SCHEMBL8021166 | 0.82 | HTR2A (0.61) | HTR2ACYP3A4HPGDHTR2CCYP1A2 | |
| SCHEMBL464537 | 0.82 | HTR2A (0.72) | HTR2ACYP3A4HPGDHTR2CCYP1A2 | |
| Hydrochloric Acid SCHEMBL8019007 | 0.80 | KMT2A (0.57) | HTR2ACYP3A4HPGDHTR2CCYP1A2 | |
| Ketanserin SCHEMBL34294 | 0.80 | HTR2A (1.00) | HTR2ACYP3A4HPGDHTR2CCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250206776-A1 | ENZYME-INSTRUCTED SELF-ASSEMBLY OF PEPTIDES CONTAINING N-TERMINAL PHOSPHO-AROMATIC CAPPING MOTIF, AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2025-06-26 | — | — | US | claimed |
| CN-117767947-A | Real-time design and frequency response calibration method and device for DBI-DAC system | 深圳华中科技大学研究院 | 2024-03-26 | — | — | CN | claimed |
| WO-2023039174-A2 | ENZYME-INSTRUCTED SELF-ASSEMBLY OF PEPTIDES CONTAINING N-TERMINAL PHOSPHO-AROMATIC CAPPING MOTIF, AND USES THEREOF | BANDEIS UNIVERSITY (US) | 2023-03-16 | — | — | WO | claimed |
| US-20250206776-A1 | ENZYME-INSTRUCTED SELF-ASSEMBLY OF PEPTIDES CONTAINING N-TERMINAL PHOSPHO-AROMATIC CAPPING MOTIF, AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2025-06-26 | — | — | US | disclosed |
| US-20250200802-A1 | Multi-Stage Object Pose Estimation | SIEMENS AKTIENGESELLSCHAFT (DE) | 2025-06-19 | — | — | US | disclosed |
| US-12335074-B2 | Multi-tap decision feed-forward equalizer with precursor and postcursor taps | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2025-06-17 | — | — | US | disclosed |
| US-12176912-B2 | Electronic devices converting input signals to digital value and operating methods of electronic devices | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-12-24 | — | — | US | disclosed |
| US-20240372759-A1 | SERDES RECEIVER WITH OPTIMIZED CDR PULSE SHAPING | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2024-11-07 | — | — | US | disclosed |
| US-12074737-B2 | SerDes receiver with optimized CDR pulse shaping | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2024-08-27 | — | — | US | disclosed |
| US-20240223413-A1 | MULTI-TAP DECISION FEED-FORWARD EQUALIZER WITH PRECURSOR AND POSTCURSOR TAPS | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2024-07-04 | — | — | US | disclosed |
| EP-4359533-A2 | COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF GENES | Versameb AG (CH) | 2024-05-01 | — | — | EP | disclosed |
| CN-116737052-A | Electronic device for converting input signal into digital value and operation method thereof | 三星电子株式会社 | 2023-09-12 | — | — | CN | disclosed |
| WO-2023039174-A2 | ENZYME-INSTRUCTED SELF-ASSEMBLY OF PEPTIDES CONTAINING N-TERMINAL PHOSPHO-AROMATIC CAPPING MOTIF, AND USES THEREOF | BANDEIS UNIVERSITY (US) | 2023-03-16 | — | — | WO | disclosed |
| WO-2022269356-A2 | COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF GENES | VERSAMEB AG (CH) | 2022-12-29 | — | — | WO | disclosed |
| WO-2022258720-A1 | INTERFERON-ASSOCIATED ANTIGEN BINDING PROTEINS FOR USE FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION | EVOTEC INTERNATIONAL GMBH (DE) | 2022-12-15 | — | — | WO | disclosed |
| US-20220360476-A1 | MULTI-TAP DECISION FEED-FORWARD EQUALIZER WITH PRECURSOR AND POSTCURSOR TAPS | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2022-11-10 | — | — | US | disclosed |
| US-11398933-B2 | Multi-tap decision feed-forward equalizer with precursor and postcursor taps | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2022-07-26 | — | — | US | disclosed |
| US-20220158878-A1 | SERDES RECEIVER WITH OPTIMIZED CDR PULSE SHAPING | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2022-05-19 | — | — | US | disclosed |
| EP-3979988-A1 | SYNTHETIC LIPIDS FOR MRNA DELIVERY | TRUSTEES OF TUFTS COLLEGE (US) | 2022-04-13 | — | — | EP | disclosed |
| US-11240075-B2 | SerDes receiver with optimized CDR pulse shaping | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250206776-A1 | ENZYME-INSTRUCTED SELF-ASSEMBLY OF PEPTIDES CONTAINING N-TERMINAL PHOSPHO-AROMATIC CAPPING MOTIF, AND USES THEREOF | ANPEP, DNPEP, PTMS | HTR2A 2303/4885CYP3A4 3631/4885HPGD 4165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.